Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Naba Alsaha Medical Services CoSAU:9546 -1.76%59 Return-on-Tangible-Equity is 12.49% as of Dec. 2025, which is 47% below its 10-year median of 23.68. GuruFocus rates SAU:9546 with a GF Score™ of 59/100 and a GF Value™ of ﷼42.17 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 576 Healthcare Providers & Services companies, Naba Alsaha Medical Services Co ranks better than 56.42% on this metric.
The historical rank and industry rank for Naba Alsaha Medical Services Co's Return-on-Tangible-Equity or its related term are showing as below:
SAU:9546'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 11.68 Med: 23.68 Max: 34.51
Current: 13.26
During the past 5 years, Naba Alsaha Medical Services Co's highest Return-on-Tangible-Equity was 34.51%. The lowest was 11.68%. And the median was 23.68%.
SAU:9546's Return-on-Tangible-Equity is ranked better than 56.42% of 576
companies
in the Healthcare Providers & Services industry
Industry Median: 10.17
vs SAU:9546: 13.26
Naba Alsaha Medical Services Co (SAU:9546) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Naba Alsaha Medical Services Co Return-on-Tangible-Equity Related Terms
Naba Alsaha Medical Services Co Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Naba Alsaha Medical Services Co Return-on-Tangible-Equity Chart
SAU:9546 vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Naba Alsaha Medical Services Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Naba Alsaha Medical Services Co Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Naba Alsaha Medical Services Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Naba Alsaha Medical Services Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 12.49% mean?
Naba Alsaha Medical Services Co (SAU:9546) has a Return-on-Tangible-Equity of 12.49% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Naba Alsaha Medical Services Co and its competitors. This is 47% below median its historical median of 23.68. Over the past decade, Naba Alsaha Medical Services Co's Return-on-Tangible-Equity has ranged from 11.68 to 34.51. According to the industry distribution chart, Naba Alsaha Medical Services Co ranks #251 out of 576 companies in the Healthcare Providers & Services industry, placing it in the top 43.6%.
Is Naba Alsaha Medical Services Co's Return-on-Tangible-Equity too high?
Naba Alsaha Medical Services Co's current Return-on-Tangible-Equity of 12.49% is 47% below median its 10-year median of 23.68. Over the past 10 years, this metric has ranged from a low of 11.68 to a high of 34.51. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.17. Naba Alsaha Medical Services Co's value of 12.49% is 22.8% above this industry median. Based on the distribution chart, Naba Alsaha Medical Services Co ranks #251 out of 576 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Naba Alsaha Medical Services Co has a GF Score™ of 59/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Naba Alsaha Medical Services Co's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Naba Alsaha Medical Services Co ranks #251 out of 576 companies for Return-on-Tangible-Equity. This puts Naba Alsaha Medical Services Co in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.17. Naba Alsaha Medical Services Co's value of 12.49% is 22.8% above this benchmark. Historically, Naba Alsaha Medical Services Co's own Return-on-Tangible-Equity has ranged from 11.68 to 34.51 over the past decade. While the company's 10-year median is 23.68 vs. the industry median of 10.17, Naba Alsaha Medical Services Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.17, based on 576 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Naba Alsaha Medical Services Co's current Return-on-Tangible-Equity of 12.49% is 22.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Naba Alsaha Medical Services Co and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Naba Alsaha Medical Services Co's current Return-on-Tangible-Equity is 12.49%, which is 47% below median its own 10-year median of 23.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naba Alsaha Medical Services Co stock overvalued right now?
Based on GuruFocus' analysis, Naba Alsaha Medical Services Co (SAU:9546) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼42.17, compared to a current price of ﷼20.63 — trading 51.1% below its estimated fair value. The current Return-on-Tangible-Equity is 12.49%, which is 47% below median its 10-year median of 23.68 and 22.8% above the Healthcare Providers & Services industry median of 10.17. Naba Alsaha Medical Services Co's overall GF Score™ is 59/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Naba Alsaha Medical Services Co (SAU:9546), the current Return-on-Tangible-Equity is 12.49% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Naba Alsaha Medical Services Co (SAU:9546) Overvalued in 2026?
Based on GuruFocus' analysis, Naba Alsaha Medical Services Co stock appears to be undervalued.
The current stock price of ﷼20.63 is trading 51.1% below its estimated GF Value™ of ﷼42.17.
GuruFocus considers Naba Alsaha Medical Services Co to be Significantly Undervalued.
Key valuation signals for SAU:9546:
Return-on-Tangible-Equity: 12.49% (47% below median its 10-year median of 23.68)
GF Value™: ﷼42.17 vs. price of ﷼20.63 (51.1% below fair value)
Industry Position: 22.8% above the Healthcare Providers & Services median (#251 of 576)
No single metric tells the full story. See the SAU:9546 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Naba Alsaha Medical Services Co Business Description
Naba Alsaha Medical Services Co is engaged in the medical operation of private and government hospitals, health facilities, and hospital-related activities. It operates and manages Al-Zahraa Hospital, Manarat Al-Haramain Pharmacy, and the Nabaa Al-Saha branch for the practice of maintenance work and the operation of buildings. Geographically, it operates in the Kingdom of Saudi Arabia.
59GF Score
Get the complete analysis for SAU:9546
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:9546 has been successfully added to your 
